307 related articles for article (PubMed ID: 10498605)
1. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).
Kirshenbaum AS; Goff JP; Semere T; Foster B; Scott LM; Metcalfe DD
Blood; 1999 Oct; 94(7):2333-42. PubMed ID: 10498605
[TBL] [Abstract][Full Text] [Related]
2. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
Rottem M; Okada T; Goff JP; Metcalfe DD
Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
[TBL] [Abstract][Full Text] [Related]
3. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.
Valent P; Spanblöchl E; Sperr WR; Sillaber C; Zsebo KM; Agis H; Strobl H; Geissler K; Bettelheim P; Lechner K
Blood; 1992 Nov; 80(9):2237-45. PubMed ID: 1384799
[TBL] [Abstract][Full Text] [Related]
4. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
[TBL] [Abstract][Full Text] [Related]
5. Transitional changes in immunophenotypic subpopulations of human peripheral blood CD34+ cells expanded in vitro.
Koizumi K; Sawada K; Sato N; Hirayama S; Yasukouchi T; Yamaguchi M; Takahashi TA; Sekiguchi S; Koike T
Exp Hematol; 1994 Nov; 22(12):1171-8. PubMed ID: 7523169
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation.
Shimizu Y; Sakai K; Miura T; Narita T; Tsukagoshi H; Satoh Y; Ishikawa S; Morishita Y; Takai S; Miyazaki M; Mori M; Saito H; Xia H; Schwartz LB
Clin Exp Allergy; 2002 Jun; 32(6):872-80. PubMed ID: 12047434
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro.
Weich NS; Fitzgerald M; Wang A; Calvetti J; Yetz-Aldape J; Neben S; Turner KJ
Blood; 2000 Jan; 95(2):503-9. PubMed ID: 10627455
[TBL] [Abstract][Full Text] [Related]
8. Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines.
Chaves-Dias C; Hundley TR; Gilfillan AM; Kirshenbaum AS; Cunha-Melo JR; Metcalfe DD; Beaven MA
J Immunol; 2001 Jun; 166(11):6647-56. PubMed ID: 11359819
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated gene transduction of c-kit into single hematopoietic progenitor cells from cord blood enhances erythroid colony formation and decreases sensitivity to inhibition by tumor necrosis factor-alpha and transforming growth factor-beta1.
Lu L; Heinrich MC; Wang LS; Dai MS; Zigler AJ; Chai L; Broxmeyer HE
Blood; 1999 Oct; 94(7):2319-32. PubMed ID: 10498604
[TBL] [Abstract][Full Text] [Related]
11. Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors.
Shimizu Y; Suga T; Maeno T; Tsukagoshi H; Kawata T; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
Clin Exp Allergy; 2004 Nov; 34(11):1719-24. PubMed ID: 15544596
[TBL] [Abstract][Full Text] [Related]
12. Growth of human mast cells from bone marrow and peripheral blood-derived CD34+ pluripotent progenitor cells.
Kirshenbaum AS; Metcalfe DD
Methods Mol Biol; 2006; 315():105-12. PubMed ID: 16110152
[TBL] [Abstract][Full Text] [Related]
13. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
Catlett JP; Leftwich JA; Westin EH; Grant S; Huff TF
Blood; 1991 Dec; 78(12):3186-91. PubMed ID: 1720696
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors.
Oskeritzian CA; Wang Z; Kochan JP; Grimes M; Du Z; Chang HW; Grant S; Schwartz LB
J Immunol; 1999 Nov; 163(9):5105-15. PubMed ID: 10528217
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.
Kinoshita T; Sawai N; Hidaka E; Yamashita T; Koike K
Blood; 1999 Jul; 94(2):496-508. PubMed ID: 10397717
[TBL] [Abstract][Full Text] [Related]
16. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
17. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE
Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371
[TBL] [Abstract][Full Text] [Related]
18. Study of early hematopoietic precursors in human cord blood.
Abboud M; Xu F; LaVia M; Laver J
Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.
Kirshenbaum AS; Kessler SW; Goff JP; Metcalfe DD
J Immunol; 1991 Mar; 146(5):1410-5. PubMed ID: 1704394
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
